Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LOGOS trial of triple inhaled therapy versus dual inhaled therapy in inadequately controlled asthma
MOH_2021-08-03_010049Phase 3Recruiting
- Sponsor
- AstraZeneca
- Start
- Jul 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Breztri Aerosphere, budesonide, glycopyrronium and formoterol in asthma (4 arms), sponsored by AstraZeneca. Started Jul 2021; status: recruiting.
02
Drugs
Breztri Aerospherebudesonideglycopyrroniumformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on MOH_2021-08-03_010049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2021-08-03_010049.